Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations

Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations

Saved in:

Bibliographic Details
Main Authors:	Loreta A. Kondili, Maria Giovanna Quaranta, Massimo Andreoni
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	The Lancet Regional Health. Europe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776225000146
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

Accelerating the fight towards malaria elimination: Bridging gaps to achieve health equity in India
by: Vani H Chalageri, et al.
Published: (2025-04-01)

Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
by: Young Joo Park, et al.
Published: (2025-01-01)

HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective studyResearch in context
by: Monica Monti, et al.
Published: (2025-02-01)

Advancing Health Equity for the Disadvantaged: The Transformative Role of Social Work in Bridging the Gap
by: Anoop C Choolayil, et al.
Published: (2024-12-01)

Advancing Health Equity for the Disadvantaged: The Transformative Role of Social Work in Bridging the Gap
by: Anoop C Choolayil, et al.
Published: (2024-12-01)

Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort
by: Antoanela Curici, et al.
Published: (2025-01-01)

Seroprevalence and associated risk factors of HBV and HCV infections in the population of Ghudduwah Village, South Libya
by: Ahmed A Khalaf, et al.
Published: (2025-01-01)

HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
by: Alexia Anastasia Stefania Balta, et al.
Published: (2025-05-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

Glances in Immunology of HIV and HCV Infection
by: Maria Giovanna Quaranta, et al.
Published: (2012-01-01)

Assessment of pathomorphological characteristics of the oral mucosa in patients with HBV, HCV and HIV
by: Vahe Azatyan, et al.
Published: (2021-11-01)

Seroprevalence of HIV, HBV, HCV & RPR among cornea donor in the regional institute of ophthalmology
by: M H Patel, et al.
Published: (2017-01-01)

Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study
by: Henry A. Adeola, et al.
Published: (2025-07-01)

Elimination of hcv-infection: a history with continuation
by: K. V. Zhdanov, et al.
Published: (2018-12-01)

Features of clinical course of chronic hepatites of mixed viral (HBV+HCV) etiologies
by: G. K. Mirodzhov, et al.
Published: (2009-10-01)

Editorial: HIV/HBV and/or HCV infections and hepatotoxicity in pregnant and non-pregnant women
by: George Uchenna Eleje, et al.
Published: (2025-08-01)

Seroprevalence of HIV, HBV, HCV and Syphilis among Blood donors at a tertiary care hospital
by: Bindu Madhavi R, et al.
Published: (2020-03-01)

Bridging the gaps: Prioritizing research strategies for enhanced malaria control and elimination
by: Rashed Alghamdi
Published: (2025-01-01)

Advances in Thermoelectric Materials—Bridging the Gap Between Discovery and Application
by: Marco Fronzi, et al.
Published: (2024-10-01)

Bridging the gap: ctDNA, genomics, and equity in breast cancer care
by: Julia Aronson, et al.
Published: (2025-08-01)

HBV and HCV serological monitoring among injection drugs users in opiate substitution treatment in Bosnia and Herzegovina
by: Sinisa Skocibusic, et al.
Published: (2016-09-01)

Seroprevalence of HIV, HBV, HCV and Syphilis among blood donors in a Nigerian tertiary medical centre
by: Ismail Habibu, et al.
Published: (2025-04-01)

The prevalence of HBV, HCV, and HIV among hemodialysis patients in a tertiary care hospital in Mashhad, Iran
by: Mohammad-Bagher Khorrami, et al.
Published: (2023-08-01)

HIV, HBV and HCV Coinfection Prevalence in Iran--A Systematic Review and Meta-Analysis.
by: Fahimeh Bagheri Amiri, et al.
Published: (2016-01-01)

Impact of HCV elimination on metabolism markers in people living with HIV
by: Andrés Deza de la Casa, et al.
Published: (2025-05-01)

肝细胞癌与HCV、HBV感染关系的病例对照研究
Published: (1994-01-01)

Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques.
by: Claudia Geue, et al.
Published: (2015-01-01)

MACHINE LEARNING-BASED CLASSIFICATION OF HBV AND HCV-RELATED HEPATOCELLULAR CARCINOMA USING GENOMIC BIOMARKERS
by: Sami Akbulut, et al.
Published: (2022-10-01)

Bridging the Health Equity Gap: An Update from the U.S. Food and Drug Administration Office of Minority Health and Health Equity
by: Richardae Araojo, et al.
Published: (2024-12-01)

Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study
by: Claudinei Mesquita da Silva, et al.
Published: (2018-11-01)

The comparative description of clinical course, injury an regeneration of liver while chronic HBV- and HCV- infections course
by: V. E. Karev, et al.
Published: (2014-09-01)

A new perspective on risk factors for progressive liver fibrosis in patients with HIV, HBV, HCV superinfection
by: E. P. Feoktistova, et al.
Published: (2024-10-01)

A Turbidity Test Based Centrifugal Microfluidics Diagnostic System for Simultaneous Detection of HBV, HCV, and CMV
by: Hung-Cheng Chang, et al.
Published: (2015-01-01)

HCV self-testing: Bridging screening gaps and ensuring cost-effectiveness for both high-risk and universal populations: Correspondence to editorial on “Self-testing strategy to eliminate hepatitis C as per World Health Organization’s goal: Analysis of disease burden and cost-effectiveness”
by: Gyeongseon Shin, et al.
Published: (2025-04-01)

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
by: Pietro Torre, et al.
Published: (2024-11-01)

Seroprevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) among Blood Donors from Bahir Dar, Ethiopia
by: Ayenew Assefa, et al.
Published: (2022-01-01)

Bridging the gaps in Mpox vaccine equity: insights and imperatives from the Philippine public health landscape
by: Danilo V. Rogayan
Published: (2025-08-01)

Bridging the Knowledge Gaps in Cancer Medicine: A Call for Precision, Equity and Real-World Evidence
by: Marcus Vetter
Published: (2025-02-01)

RACGAP1 and MKI67 are potential prognostic biomarker in hepatocellular carcinoma caused by HBV/HCV via lactylation
by: Muhammad Muddasar Saeed, et al.
Published: (2025-05-01)